Zydus Lifesciences Limited is an India-based life-sciences company with positions across pharmaceuticals and consumer wellness, supported by a MedTech franchise and a global footprint across United States, India and other international markets. Its pharmaceutical business includes integrated pharmaceutical operations with business encompassing the entire value chain in research, development, production, marketing and distribution of pharmaceutical products. Its product portfolio includes active pharmaceutical ingredients, human formulations, and animal health and veterinary. Its consumer products business includes development, production, marketing and distribution of differentiated health and wellness products. It provides biologicals manufacturing sites offering contract development and manufacturing organization services to biopharmaceutical companies globally. Its focused therapy areas include cardiology, anti-diabetes, super specialty areas of oncology and nephrology, and others.As of 25 May 2026, Zydus Lifesciences share price is ₹1,072.95. The stock opened at ₹1,049.80, compared to its previous close of ₹1,038.95. During today's trading session, Zydus Lifesciences share price moved in the range of ₹1,041.50 to ₹1,075.00, with an average price of ₹1,058.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,041.50 and a high of ₹1,075.00. On the performance front, Zydus Lifesciences share price has increased by 12.40% over the last six months and is up 15.00% on a year-on-year basis.
The market capitalization of Zydus Lifesciences is ₹1,04,543 Crs, with a P/E ratio of 20.4 and a dividend yield of 0.10%.